menu
    • menu

    Company profile for Aptevo Therapeutics

    NEW Drugs in Dev: 10
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a resul...
    Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, etc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aptevo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2401 4th Avenue, Suite 1050 Seattle, WA 98121
    Telephone
    Telephone
    206-838-0500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aptevotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptevo Pharma Secures $60M Credit Line For Portfolio Advancement
    Aptevo Pharma Secures $60M Credit Line For Portfolio Advancement

    09 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-09/aptevo-therapeutics-secures-60-million-equity-line-of-credit-to-support-multispecific-portfolio-adv

    PHARMIWEB
    09 Jan 2026
    Share Share
    Aptevo Therapeutics Announces 1-For-18 Reverse Stock Split
    Aptevo Therapeutics Announces 1-For-18 Reverse Stock Split

    26 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-26/aptevo-therapeutics-announces-1-for-18-reverse-stock-split

    PHARMIWEB
    26 Dec 2025
    Share Share
    Aptevo Pharma Showcases Mipletamig Safety & Efficacy in AML
    Aptevo Pharma Showcases Mipletamig Safety & Efficacy in AML

    09 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-09/aptevo-therapeutics-highlights-compelling-safety-and-strong-remission-rates-for-mipletamig-in-frontl

    PHARMIWEB
    09 Dec 2025
    Share Share
    Aptevo's 1st Trispecific APVO451 Preclinical Data In Solid Tumors
    Aptevo's 1st Trispecific APVO451 Preclinical Data In Solid Tumors

    10 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-10/aptevo-debuts-first-trispecific-antibody-candidate-apvo451-with-preclinical-data-demonstrating-imm

    PHARMIWEB
    10 Nov 2025
    Share Share
    Aptevo Therapeutics Reports 3Q25 Financial Results & Business
    Aptevo Therapeutics Reports 3Q25 Financial Results & Business

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/aptevo-therapeutics-reports-3q25-financial-results-and-provides-a-business-update

    PHARMIWEB
    06 Nov 2025
    Share Share
    Aptevo Presenting Scientific and Clinical Updates at SITC and ASH
    Aptevo Presenting Scientific and Clinical Updates at SITC and ASH

    08 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-08/aptevo-presenting-scientific-and-clinical-updates-at-sitc-and-ash-also-participating-in-leading-fin

    PHARMIWEB
    08 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search